Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2001-12-17
2008-12-02
Romeo, David S (Department: 1647)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S388100, C530S388150, C530S388200, C530S387300, C530S391100, C530S391300, C530S391700, C530S809000
Reexamination Certificate
active
07459539
ABSTRACT:
A novel gene (designated 108P5H8) and its encoded protein, and variants thereof, are described wherein 108P5H8 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 108P5H8 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 108P5H8 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 191P1E1B can be used in active or passive immunization.
REFERENCES:
patent: 5869045 (1999-02-01), Hellstrom et al.
patent: 1033401 (2000-09-01), None
patent: WO 9733605 (1997-09-01), None
patent: WO0055174 (2000-09-01), None
patent: WO0159063 (2001-08-01), None
patent: WO0160860 (2001-08-01), None
patent: WO0210449 (2002-02-01), None
patent: WO0218632 (2002-03-01), None
patent: WO 0224718 (2002-03-01), None
patent: WO0224718 (2002-03-01), None
patent: WO0230268 (2002-04-01), None
patent: WO02055700 (2002-07-01), None
patent: WO 02060953 (2002-08-01), None
patent: WO 03050236 (2003-06-01), None
Murgia et al. Cloning, expression, and vesicular localization of zinc transporter Dri 27/ZnT4 in intestinal tissue and cells. Am J Physiol 277 (Gastrointest Liver Physiol 40): G1231-G1239, 1999.
Kaufman et al. Blood 9: 3178-3184, 1999.
Wang et al. Rapid analysis of gene expression (RAGE) facilitates universal expression profiling. Nucleic Acids Res 27(23): 4609-4618, 1999.
Campbell et al. Totipotency of multipotentiality of cultured cells: applications and progress. Theriogenology 47: 63-72, 1997.
Moore, G. Genetically engineered antibodies. Clin Chem 35(9): 1849-1853, 1989.
Dillman et al. Monoclonal antibodies in the treatment of malignancy: basic concepts and recent developments. Cancer Invest 19(8): 833-841, 2001.
Skolnick et al. From genes to protein structure and function: novel applications of computational approaches in the genomic era. Trends in Biotech 18(1): 34-39, 2000.
Bork, A. Powers and pitfalls in sequence analysis: the 70% hurdle. Genome Res 10: 398-400, 2000.
Doerks et al. Protein annotation: detective work for function prediction. Trends in Genetics 14(6): 248-250, 1998.
Smith et al. The challenges of genome sequence annotation or “The devil is in the details”. Nature Biotech 15: 1222-1223, 1997.
Brenner, S.E. Errors in genome function. Trends in Genetics 15(4): 132-133, 1999.
Bork et al. Go hunting in sequence databases but watch out for the traps. Trends in Genetics. 12(10): 425-427, 1996.
Wells. J.A. Additivity of mutational effects in proteins. Biochemistry 29 (37): 8509-8517, 1990.
Ngo et al. Computational complexity, protein structure prediction, and the Levinthal paradox. The Protein Folding Problem and Tertiary Structure Prediction, pp. 492-495, 1994.
Daniel et al. Virology 202:540-549, 1994.
Haynes et al. Proteome analysis: biological assay or data archive. Electrophoresis 19: 1862-1871, 1998.
Hu et al. Analysis of genomic and proteomic data using advanced literature mining. J Proteome Res 2: 405-412, 2003.
Chen et al. Discordant protein and mRNA expression in lung adenocarcinomas. Molec Cellular Proteomics 1: 304-313, 2002.
Huang et al., Nature Genetics (1997) 17(3):292-297.
Hwang et al., Seminars in Oncology (1999) 26(2):192-201.
Southwood et al., Journal of Immunology (1998) 160(7):3363-3373.
Afar Daniel E. H.
Challita-Eid Pia M.
Faris Mary
Hubert Rene S.
Jakobovits Aya
Agensys, Inc.
Morrison & Foerster / LLP
Romeo David S
LandOfFree
Antibody that binds zinc transporter protein 108P5H8 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibody that binds zinc transporter protein 108P5H8, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibody that binds zinc transporter protein 108P5H8 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4029328